Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
04/2000
04/27/2000WO2000023078A1 Pharmaceutical compositions containing tetrahydroisoquinoline compounds
04/27/2000WO2000023076A1 Aminophenoxyacetic acid derivatives as neuroprotectants
04/27/2000WO2000023063A2 Methods for inhibiting diabetic complications
04/27/2000WO2000023054A1 Polyvinyl alcohol microspheres, and methods for making and therapeutic uses of the same
04/27/2000WO2000023051A1 Aerosol ointment compositions and method of manufacture
04/27/2000WO2000023045A1 Pharmaceutical composition with gastric residence and controlled release
04/27/2000WO2000005265A3 Anti-crr2 antibodies and methods of use therefor
04/27/2000WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors
04/27/2000DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies
04/27/2000CA2348153A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules
04/27/2000CA2347792A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
04/27/2000CA2347625A1 Genes and proteins predictive and therapeutic for renal disease and associated disorders
04/27/2000CA2347108A1 Aerosol ointment compositions and method of manufacture
04/27/2000CA2347080A1 Tnfr related gene 12
04/27/2000CA2346937A1 Specific therapeutic interventions obtained by interference with redistribution and/or targeting
04/27/2000CA2346798A1 Novel neuropilin/growth factor binding and uses thereof
04/27/2000CA2346436A1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h3 agonists or antagonists
04/27/2000CA2346325A1 Bioflavonoids as plasma high density lipoprotein level increasing agent
04/27/2000CA2345382A1 Inhibitors of platelet activation and recruitment
04/27/2000CA2345205A1 Polyvinyl alcohol microspheres, and methods for making and therapeutic uses of the same
04/27/2000CA2343094A1 Interferon-beta fusion proteins and uses
04/26/2000EP0995755A1 Prodrugs of Thrombin inhibitors
04/26/2000EP0995751A2 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
04/26/2000EP0995750A1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
04/26/2000EP0995743A1 Derivatives of dihydro- and tetrahydrochinoline as a medicinal antioxydans
04/26/2000EP0995439A1 Use of indazole derivatives in the manufacture of a medicament for treating congestive heart failure
04/26/2000EP0994903A1 Methods and compositions for galactosylated glycoproteins
04/26/2000EP0994896A1 Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4
04/26/2000EP0994892A1 SELECTIVE FACTOR Xa INHIBITORS
04/26/2000EP0994877A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
04/26/2000EP0994870A1 Novel aryloxy substituted pyrimidine imidazole compounds
04/26/2000EP0994861A1 NEW $g(b)-AMINO AND $g(b)-AZIDOCARBOXYLIC ACID DERIVATIVES, THE PRODUCTION THEREOF AND THE USE THEREOF AS ENDOTHELIN RECEPTOR ANTAGONISTS
04/26/2000EP0994860A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists
04/26/2000EP0994859A1 Compounds
04/26/2000EP0994857A1 (1h-imidazol-4-yl)piperidine derivatives, preparation and application in therapy
04/26/2000EP0994853A2 Compounds and methods for the inhibition of the expression of vcam-1
04/26/2000EP0994730A2 LABELLED FACTOR XIIIa SUBSTRATES
04/26/2000EP0994713A1 USE OF A 7$g(a)-METHYL-17$g(a)-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS
04/26/2000EP0865291A4 Localized intravascular delivery of tfpi for inhibition of restenosis in recanalized blood vessels
04/26/2000EP0738269B1 Piperidine derivatives with paf antagonist activity
04/26/2000EP0680469B1 Aminoacid derivates, medicaments containing these compounds and process for preparing the same
04/26/2000EP0554381B2 Use of protective agents against reactive oxygen species
04/26/2000CN1251573A Solid composition suitable for oral administration comprising non hydroscopic salts of L-carnitine or alkanoyl-L-carnitine with 2-aminoethanesulfonic acid
04/26/2000CN1251530A Use of substaces having oxytocin activity for preparation of medicaments for wound healing
04/26/2000CN1251301A Biological capsule and its preparation method
04/26/2000CN1051766C Angiotension II antagonist imidazole derivatives, their preparation and therapeutic use
04/26/2000CN1051711C External applying medicine powder for treating essential hypertension
04/26/2000CN1051703C Process for preparing medicinal composition containing oxaspiro [2,5] octane derivatives and its salt thereof
04/25/2000US6054593 Elastase inhibitor
04/25/2000US6054560 Mitogen activated protein kinase, FRK
04/25/2000US6054558 Amino acid sequence of isolated polypeptide from gene upregulated in endothelial cells in response to shear stress; for treatment and diagnosis of atherosclerosis, hypertension, ischemia/reperfusion, restenosis, and arterial inflammation
04/25/2000US6054486 Use of 9-Deoxy-2',9-α-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f1 to treat peripheral vascular disease
04/25/2000US6054457 Benzamide derivatives and their use as vasopressin antagonists
04/25/2000US6054449 Photodynamic therapy
04/25/2000US6054312 Receptor-mediated gene delivery using bacteriophage vectors
04/25/2000US6054308 Arginase II
04/25/2000US6054115 Purifying by exposing a mixture of uncoordinated hydroxyalkyl phosphine groups and coordinated hydroxyalkyl phosphine groups to an amine to separate the unbound coordinated groups from the bound uncoordinated groups
04/25/2000CA2143849C Substituted thiazolidinedione derivatives
04/25/2000CA1340977C Scavenger receptor protein and antibody thereto
04/23/2000CA2287562A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
04/21/2000CA2287139A1 Method for treating congestive heart failure
04/21/2000CA2251265A1 Process for lipid extraction of aquatic animal tissues producing a dehydrated residue
04/20/2000WO2000022143A2 Protein kinase homologs
04/20/2000WO2000022126A1 Follistatin-related protein zfsta2
04/20/2000WO2000022113A1 ENZYMATIC SYNTHESIS OF ssDNA
04/20/2000WO2000021986A2 Matrix-remodeling genes
04/20/2000WO2000021964A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and anfiinflammatory activity
04/20/2000WO2000021963A1 Il-8 receptor antagonists
04/20/2000WO2000021961A1 Imidazo-isoquinoline compounds, their compositions and uses
04/20/2000WO2000021959A1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use
04/20/2000WO2000021955A1 Quinazoline derivatives
04/20/2000WO2000021954A1 Novel heterocyclyl-methyl-substituted pyrazoles
04/20/2000WO2000021930A1 Esters of (+)-alpha-( 2,3- dimethoxyphenyl) -1-[2-(4- fluorophenyl) ethyl]-4- piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907
04/20/2000WO2000021920A1 Diaminopropionic acid derivatives
04/20/2000WO2000021557A1 Delta 6 fatty acid desaturase
04/20/2000WO2000021548A2 Angiogenically effective unit dose of fgf and method of administering
04/20/2000WO2000021533A1 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound
04/20/2000WO2000021525A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
04/20/2000WO2000021521A2 Sertraline oral concentrate
04/20/2000WO2000021519A1 Drug preparation 'histochrome' for treating acute myocardial infarction and ischaemic heart diseases
04/20/2000WO2000021509A2 Methods of treatment
04/20/2000WO2000005245A3 Inhibitors of urokinase and blood vessel formation
04/20/2000WO2000003994A3 Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them
04/20/2000WO2000001713A9 Diacylglycerol acyl transferase proteins
04/20/2000WO1999065571A3 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
04/20/2000WO1999064050A9 Novel potassium channel drugs and their uses
04/20/2000WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors
04/20/2000WO1999063981A3 Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells
04/20/2000DE19846514A1 New arylmethyl and heterocyclylmethyl substituted heteroaryl-indazole derivatives useful in treatment of cardiovascular, ischemic and urogenital disorders
04/20/2000DE19845405A1 Arylsubstituierte Propanolaminderivate und deren Verwendung Aryl-substituted Propanolaminderivate and their use
04/20/2000DE19845372A1 Verwendung von Katecholderivaten als Proteinaseninhibitoren Using catechol as proteinase inhibitors
04/20/2000CA2347968A1 Follistatin-related protein zfsta2
04/20/2000CA2346775A1 Protein kinase homologs
04/20/2000CA2346698A1 Novel heterocyclyl-methyl-substituted pyrazoles
04/20/2000CA2346542A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and antiinflammatory activity
04/20/2000CA2346414A1 Imidazo-isoquinoline compounds, their compositions and uses
04/20/2000CA2346155A1 Enzymatic synthesis of ssdna
04/20/2000CA2346006A1 Delta 6 fatty acid desaturase
04/20/2000CA2315375A1 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound
04/20/2000CA2314004A1 Matrix-remodeling genes
1 ... 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 ... 1595